Australian biotech market today 05.05.09

By Kate McDonald
Tuesday, 05 May, 2009

The healthcare index is down three per cent today at 2.00pm, bucking the trend of most of the other indices, which were up 0.5 per cent overall.

The trend was predominantly due to falls in the Big Three, with Cochlear (ASX:COH) down $2, CSL (ASX:CSL) down $1 and ResMed (ASX:RMD) down 4c.

Sirtex (ASX:SRX) was down 7c to $3.08 while Sonic Healthcare (ASX:SHL) was down 46c to $11.14.

BioDiem (ASX:BDM) and Avexa (ASX:AVX) were both down to 9 cents each, despite Avexa raising some much needed cash recently.

A bright spot was Pharmaxis (ASX:PXS), up 37c to $2.65 on today’s positive data from its Phase III trial of Bronchitol in cystic fibrosis. Marketing approval in Europe looks certain for this product and the company has others in the pipeline.

Acrux (ASX:ACR) was up 3.5 per cent on small volumes, and Cellestis (ASX:CST) was up a healthy 11c to $2.83. Mesoblast (ASX:MSB) was up 5c on small volumes.

Related News

Less penicillin needed to treat Strep A infection than we thought

It's never been known exactly how much penicillin prevents sore throats — the most...

Stress disrupts emotion control in mental illness

Acute stress may impair key brain functions involved in managing emotions — particularly in...

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd